feed,title,long_url,short_url
BioRxiv,A novel consensus-based computational pipeline for rapid screening of antibody therapeutics for efficacy against SARS-CoV-2 variants of concern including omicron variant,https://biorxiv.org/cgi/content/short/2022.02.11.480177v1?rss=1,https://bit.ly/3JvfeqZ
BioRxiv,SARS-CoV-2-specific T cells associate with reduced lung function and inflammation in pulmonary post-acute sequalae of SARS-CoV-2,https://biorxiv.org/cgi/content/short/2022.02.14.480317v1?rss=1,https://bit.ly/3gLEVav
BioRxiv,Increased Potency and Breadth of SARS-CoV-2 Neutralizing Antibodies After a Third mRNA Vaccine Dose,https://biorxiv.org/cgi/content/short/2022.02.14.480394v1?rss=1,https://bit.ly/3GMDVNH
